SCHEMBL11297190

SCHEMBL11297190

O=C1CC(N(c2ccccc2)c2ccc(C(=O)NO)cc2)CN1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 11/20 0.44
▸ HDAC1 Q13547 10/20 0.44
▸ HDAC8 Q9BY41 9/20 0.44
▸ HDAC2 Q92769 3/20 0.42
▸ HDAC3 O15379 2/20 0.42
▸ NCOR2 Q9Y618 2/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ IDO1 P14902 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ HDAC7 Q8WUI4 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ HDAC4 P56524 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11303497 0.89 HDAC8 (0.46) HDAC6HDAC1HDAC8HDAC2ALOX15
SCHEMBL11300774 0.89 HDAC6 (0.41) HDAC6HDAC1HDAC8HDAC3ALOX15
SCHEMBL11303321 0.87 HDAC8 (0.44) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL11297461 0.86 HDAC8 (0.37) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL11296626 0.85 HDAC8 (0.49) HDAC1HDAC8CA1KDM4EOPRM1
SCHEMBL11303510 0.84 MEN1 (0.47) MEN1KMT2AOPRM1OPRD1
SCHEMBL11299059 0.82 HDAC6 (0.48) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL11299511 0.80 HDAC8 (0.41) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL11372589 0.80 HDAC1 (0.48) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL11301919 0.80 HDAC1 (0.48) HDAC6HDAC1HDAC8HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback